The Saul R. Korey Department of Neurology

Research and Clinical Trials

Research: Neurodegenerative Clinical Trials
Principal Investigator: Jessica Zwerling MD MS

 

Recruiting

Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI) 

Condition:  

Mild Cognitive Impairment

Intervention:  

Drug: [18F]NAV4694
Recruiting

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology 

Conditions:  

Dementia;   Alzheimer's Disease

Intervention:  

Drug: [18F]NAV4694
 

Integrated Divisions of Cognitive & Motor Aging and Geriatrics 
 

Einstein Aging Study 
  Health in Aging 

Department Chairman

Mark Mehler Mark F. Mehler, M.D. (bio)

Professor of Neuroscience
Professor of Psychiatry and Behavioral Sciences
Chair of The Saul R. Korey Department of Neurology
Alpern Family Foundation Chair in Cerebral Palsy Research
Director, Institute for Brain Disorders and Neural Regeneration

Letter from the Chairman